Valuation: MaaT Pharma

Market Cap 59.36M 69.2M 55.43M 50.85M 95.63M 6.61B 97.2M 654M 256M 3.32B 260M 254M 10.97B P/E 2026 *
-1.65x
P/E 2027 * -2.83x
Enterprise Value 70.66M 82.38M 65.98M 60.54M 114M 7.87B 116M 779M 305M 3.95B 309M 303M 13.06B EV / Sales 2026 *
7.25x
EV / Sales 2027 * 3.25x
Free-Float
36.85%
Yield 2026 *
-
Yield 2027 * -
1 day+7.51%
1 week+8.62%
Current month+13.31%
1 month+17.54%
3 months-53.40%
6 months-58.98%
Current year-34.51%
1 week 2.88
Extreme 2.88
3.38
1 month 2.62
Extreme 2.62
3.38
Current year 2.32
Extreme 2.32
8.62
1 year 2.32
Extreme 2.32
8.62
3 years 2.32
Extreme 2.32
9.96
5 years 2.32
Extreme 2.32
14.4
10 years 2.32
Extreme 2.32
14.4
Manager TitleAgeSince
Chief Executive Officer - 01/01/2014
Director of Finance/CFO 59 01/11/2024
Chief Tech/Sci/R&D Officer - 24/06/2024
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member 57 01/01/2014
Chairman - 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
29/01/26
Seventure Partners SA
SellCompany 25,423 0.1356%
28/01/26
Seventure Partners SA
SellCompany 57,964 0.3091%
14/01/26
Seventure Partners SA
SellCompany 4,755 0.0254%
Change 5-day change 1-year change 3-year change Capi.($)
+7.51%+8.62%-46.61%-50.78% 63.92M
-1.90%+3.12%+81.70%+110.88% 73.45B
+0.87%+15.32%+56.99%+95.59% 62.99B
+1.71%-1.22%+2.71%+501.29% 28.05B
+6.05%+11.44%+66.39%+28.02% 25.42B
+21.96%+21.98%+1.54%+2.50% 23.3B
+2.28%+5.65%+42.00%-12.34% 19.45B
0.00%-2.78%+247.46%+423.83% 18.16B
+5.06%+4.57%+27.49%+546.47% 16.53B
+2.39%+7.96%+44.96%+157.77% 13.16B
Average +4.62%+6.08%+52.46%+180.32% 28.06B
Weighted average by Cap. +2.83%+6.43%+63.25%+169.52%

Financials

2026 *2027 *
Net sales 9.75M 11.37M 9.1M 8.35M 15.71M 1.09B 15.97M 107M 42.07M 545M 42.68M 41.75M 1.8B 28.88M 33.66M 26.96M 24.74M 46.52M 3.22B 47.29M 318M 125M 1.61B 126M 124M 5.34B
Net income -31.69M -36.95M -29.59M -27.15M -51.06M -3.53B -51.9M -349M -137M -1.77B -139M -136M -5.86B -15.31M -17.85M -14.3M -13.12M -24.67M -1.71B -25.07M -169M -66.06M -856M -67.02M -65.56M -2.83B
Net Debt 11.3M 13.18M 10.56M 9.68M 18.21M 1.26B 18.51M 125M 48.77M 632M 49.48M 48.4M 2.09B 34.5M 40.22M 32.21M 29.56M 55.58M 3.84B 56.49M 380M 149M 1.93B 151M 148M 6.37B
Logo MaaT Pharma
MaaT Pharma is a late-stage biotechnology company and a leader in the development of intestinal microbiota-based drugs designed to modulate the immune system of cancer patients and improve their survival. A pioneer in its field, MaaT Pharma is developing the first immunomodulatory drug candidate based on intestinal microbiota in oncology, currently in phase 3 clinical evaluation. Thanks to its proprietary pooling (combining donations of healthy microbiota) and microbial co-culture technologies, MaaT Pharma is developing standardised drugs with high bacterial diversity, aimed at improving the survival of cancer patients.
Employees
56
Date Price Change Volume
19/08/26 €3.150 +7.51% 164,209
18/08/26 €2.930 -1.51% 8,569
17/08/26 €2.975 +2.94% 19,523
14/08/26 €2.890 -2.03% 33,670
13/08/26 €2.950 +1.72% 39,076
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.150EUR
Average target price
6.500EUR
Spread / Average Target
+106.35%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MAAT Stock